Lactic acid can alleviate lipid metabolism disorders in NAFLD induced by diet through the inhibition of inflammation mediated by the NLRP3 inflammasome and the regulation of the autophagy process. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.